What Happened to the 2027 Star Ratings?
CMS published the 2027 Medicare Advantage and Part D Star Ratings on October 8, 2026. The average enrollment-weighted rating for Medicare Advantage prescription drug (MA-PD) contracts slipped from 4.01 to 3.99 stars, and only 15 MA-PD contracts earned five stars, down from 22. Those figures come from the CMS 2027 Star Ratings fact sheet. The ratings appear on Medicare Plan Finder for this Annual Enrollment Period (AEP), and they determine quality bonus payments in 2028.
Within weeks, the lawsuits started. Becker’s Payer Issues counts at least six insurers suing CMS over their 2027 ratings. All of them make a similar argument: CMS calculated scores using quality measures that were never formally adopted through notice-and-comment rulemaking. Several insurers lean on a ruling earlier this year in a case brought by Clover Health, in which a federal court in Georgia found that CMS had used measures without the required rulemaking.
Broker Takeaway
Clients won’t ask you about the Administrative Procedure Act. They will ask, “Is this a good plan?” and point at the stars. The agent who can explain what a rating measures, and how much weight to give it, earns trust that a mailer never will.
The 2027 Numbers From CMS
Here’s how the 2027 ratings compare with 2026, according to the CMS fact sheet. Full data tables are on the CMS Part C and D performance data page.
Two details deserve attention. First, the share of enrollees in four-star-or-better contracts actually rose, even as the number of high-rated contracts fell. The large plans that hold most members did comparatively well, while many smaller contracts slipped. Second, no stand-alone Part D plan earned five stars for 2027, which limits how the 5-star SEP works for Medigap clients (more on that below).
Results by carrier varied widely. Analysts at J.P. Morgan estimate that about 67% of UnitedHealth’s MA members are in plans rated four stars or higher for 2027, down from 81%, and about 70% of CVS Health’s, down from 84%, according to Investing.com. Humana went the other way. Its largest contract, H5216, rose from 3.5 to 4 stars, and Investing.com reports that about 95% of Humana members are now in four-star-plus plans, up from 20%.
CMS also changed the methodology. Two new Part D safety measures joined the 2027 ratings, covering concurrent use of opioids and benzodiazepines and the use of multiple anticholinergic drugs in older adults. The physical and mental health outcome measures now count three times as much as before. Separately, the CY2027 final rule drops the planned health equity reward, keeps the historical reward factor, and removes a set of administrative measures starting with future rating years.
The Six Lawsuits, Explained
Becker’s Payer Issues summarized the cases filed so far. Each plaintiff asks a court to set aside some measures and have CMS recalculate its ratings:
Why does a half star matter so much? Under federal law, MA plans rated four stars or higher earn quality bonus payments, and the rating also affects how much of each plan’s rebate it keeps to fund extra benefits. A drop from 4 to 3.5 stars can cut hundreds of millions of dollars from what an insurer has to spend on benefits in a future year.
What we don’t know yet. None of these cases has been decided. A court could order CMS to recalculate some ratings, as happened for Clover Health, whose contract H5141 is among the 15 five-star contracts for 2027. If ratings change mid-year, Plan Finder could change too. Until then, quote only the ratings currently on Medicare Plan Finder and don’t predict how the lawsuits will turn out.
What the Ratings Change for Clients (and What They Don’t)
This is the point many clients, and some agents, get wrong. The 2027 Star Ratings determine bonus payments in 2028. Benefits for 2027 were built on 2026 ratings, and CMS notes that 2027 payments reflect 2026 Star Ratings. So a plan that dropped half a star this fall didn’t cut its 2027 benefits because of that drop. If the lower rating holds, though, it may squeeze benefits or premiums when 2028 bids are filed next June.
- Stars measure quality, not fit. A 3.5-star plan with your client’s doctors and drugs can be a better choice than a 4.5-star plan without them.
- Ratings apply to contracts, not plans. Every plan under one contract shares the same rating, even with different networks and benefits.
- Stars look backward. Most measures reflect performance from 2025 or earlier.
- Specific measures can be more useful than the overall score. For a client who calls the plan often, “Customer Service” or “Members Choosing to Leave the Plan” can matter more than the overall number.
Broker Takeaway
Use stars as one line of the comparison, after networks, drugs and total cost. Never lead with them, and never let a rating stand in for a needs-based recommendation.
The 5-Star SEP: A Year-Round Enrollment Window
Here’s the part most agents overlook. Medicare’s 5-star Special Enrollment Period lets a beneficiary switch to a plan with a five-star overall rating once between December 8 and November 30 of the following year, as Medicare.gov explains. For 2027 five-star plans, the window runs from December 8, 2026, through November 30, 2027. That’s an enrollment opportunity for nearly the whole year, in any market with a five-star contract.
The CMS enrollment and disenrollment guidance sets out the mechanics:
- Coverage starts on the first day of the month after the plan receives the enrollment request.
- The client must meet the plan’s normal eligibility rules, such as living in the service area.
- The SEP can be used for only one enrollment per contract year.
- The last possible effective date is December 1, 2027. Requests made in December use the next year’s ratings.
The Part D catch. Medicare.gov warns that a client who moves from an MA-PD to a five-star MA plan without drug coverage may lose drug coverage and face a late enrollment penalty. Because no stand-alone PDP earned five stars for 2027, a Medigap client can’t use this SEP to switch drug plans this year. Our Part D late enrollment penalty guide covers how to explain the penalty.
A practical example
Rosa lives in a county where a five-star MA-PD contract is available. She keeps her current plan through AEP because her cardiologist’s network status is uncertain. In March, her cardiologist confirms that he is in network with the five-star plan. Using the 5-star SEP, Rosa can switch, with coverage starting April 1, even though the Medicare Advantage Open Enrollment Period ended March 31. Every five-star plan, network and drug list should be checked in Plan Finder by ZIP code.
Low-Performing Plans and the Switch Option
CMS flags MA and Part D contracts that have scored below three stars for three years in a row with a low-performing icon. For 2027, four MA-PD contracts carry it, according to the CMS fact sheet. According to Medicare.gov, members of these plans can switch to another Medicare Advantage or Part D plan at any time while they’re enrolled in the low-performing plan. If you have clients in one of these contracts, it’s a legitimate reason for a review call, with a Scope of Appointment documented first under our Scope of Appointment rules guide.
How to Discuss Star Ratings Compliantly
Star Ratings carry specific marketing rules, and the 2027 lawsuits make careless claims riskier. Keep these guardrails in place:
- Quote only the current overall rating shown on Medicare Plan Finder, and include the CMS star rating disclaimer in any material that mentions ratings: “Every year, Medicare evaluates plans based on a 5-star rating system.”
- Don’t say a rating is “wrong,” “under appeal” or “about to go up.” The lawsuits are unresolved, and predicting the outcome is speculation.
- Don’t present stars as a guarantee of care quality, access or benefits.
- Don’t use the 5-star SEP as a pressure tactic. It’s a right the client has, not a deadline.
- Document why each client chose their plan, especially when they pick a lower-rated plan for network or drug reasons.
- Use only carrier-approved materials that mention star ratings, and check your carrier’s current guidance.
Your Star Ratings Action Plan
- Before December 7: add the current overall star rating to every comparison you run, after networks, drugs and total cost.
- Flag clients in low-performing contracts and schedule reviews.
- Map your five-star markets. Use Plan Finder by ZIP code to see which counties in your book have a five-star contract.
- Build a December 8 follow-up list of clients who held back during AEP because of a network or drug question a five-star plan might solve.
- Protect drug coverage. Never move a client into a plan without Part D unless creditable coverage is confirmed.
- Track the lawsuits through carrier and FMO bulletins, and update your talking points only when CMS or a court acts.
Pair this with our AEP final checklist, the plan non-renewal playbook for clients whose plans are ending, and the 2027 benefit cuts guide. For clients weighing a move back to Original Medicare, see our Medicare Advantage vs. Medicare Supplement guide.
How Affordable Care Agents Supports Medicare Brokers
Affordable Care Agents is a national FMO, IMO and insurance brokerage. If you’re new to the model, here’s what an FMO does for brokers. Our brokers get:
- Carrier contracting across Medicare Advantage, Part D, Medicare Supplement, ancillary and life products, including five-star carriers where available
- Plain-English carrier bulletins on star ratings, benefits and commission status
- Compliance guidance on marketing claims, Scope of Appointment and documentation
- Year-round enrollment support for SEPs, plus help building renewal income. See our renewal commission guide
- AHIP 2027 certification at a discount through our OIM partnership. See our AHIP 2027 certification guide
Sell Past December 7 With Confidence
Partner with Affordable Care Agents for carrier access, compliance support and year-round SEP strategy, including the 5-star SEP.
Still need AHIP 2027? Complete it at a discount through our OIM partnership.
Frequently Asked Questions
Disclaimer: This article is provided for educational and informational purposes only and should not be considered legal, tax, financial, medical, insurance, or compliance advice. Insurance laws, Medicare and Medicaid regulations, Affordable Care Act (ACA) Marketplace rules, carrier policies, commissions, plan availability, eligibility requirements, and state regulations may change without notice and vary by jurisdiction. Readers should verify all information through official sources such as CMS, Medicare.gov, Healthcare.gov, the IRS, applicable state Departments of Insurance, and insurance carriers before making insurance or business decisions. Affordable Care Agents is a national Field Marketing Organization (FMO), Insurance Marketing Organization (IMO), and insurance brokerage. Publication does not constitute an offer of insurance or a guarantee of coverage, contracting, compensation, eligibility, or regulatory compliance. We are not connected with or endorsed by the U.S. government or the federal Medicare program.



